Selective Serotonin Reuptake Inhibitors (SSRIs) are types of antidepressants. Brand names of SSRIs include: Paxil, Zoloft, Celexa, Prozac, Lexapro, Symbyax, Wellbutrin and Effexor. These drugs inhibit neuronal serotonin and norepinephrine reuptake and slightly inhibit dopamine reuptake. SSRIs have been associated with serious, life-threatening birth defects. Research suggests that, if a mother took SSRI’s during pregnancy, […]
SC AG Files Lawsuit Against GSK for Improper Marketing of Diabetes Drug
June 3, 2011
Drug Regulators in the US and Europe Restrict Use of Avandia (rosiglitazone)
September 23, 2010
NHTSA Raises Number of Deaths Associated with Toyota Acceleration
May 26, 2010
Toyota Pays $16.4 Million Fine
May 19, 2010
Toyota Announces Plan to Replace Accelerators in Secondary Recall
March 23, 2010
SC AG Files Lawsuit Against GSK for Improper Marketing of Diabetes Drug
The Associated Press (6/1/11) reported that South Carolina Attorney General Alan Wilson filed suit May 17, 2011 against GlaxoSmithKline (GSK), alleging that GSK had improperly marketed the diabetes drug Avandia (rosiglitazone) to South Carolina consumers and hid the medication’s harmful side effects. In his complaint, Wilson argues “that the drugmaker acted negligently when it claimed that Avandia did not put patients’ hearts at risks and could actually reduce the potential for heart problems.”